
STAAR Surgical (STAA) Stock Forecast & Price Target
STAAR Surgical (STAA) Analyst Ratings
Bulls say
Staar Surgical is positioned for growth due to multiple factors: a strong recovery in China, successful execution of their restructuring plans to improve costs and efficiencies, and a favorable market for their product (phakic IOLs) with potential for expansion into new indications. Additionally, the company has potential for growth through its successful expansion into the Chinese market, as well as opportunities with the emergence of new technologies like SMILE, which could be complementary to STAAR's offerings. While there are risks, such as intensifying competition and manufacturing constraints, STAAR has a strong track record and we believe its innovative products and revenue-generating business model will continue to drive value for the company.
Bears say
Staar Surgical is facing potential risks and uncertainties due to its financials, leadership changes, and competition in China, despite its unique market position and focus on implantable lenses. The company's reliance on foreign sales poses a risk, particularly in light of its recent difficulties in China and potential threats from competitors. Additionally, the involvement of activist shareholders and the merger with Alcon could add further challenges for the company's growth and success in the coming years.
This aggregate rating is based on analysts' research of STAAR Surgical and is not a guaranteed prediction by Public.com or investment advice.
STAAR Surgical (STAA) Analyst Forecast & Price Prediction
Start investing in STAAR Surgical (STAA)
Order type
Buy in
Order amount
Est. shares
0 shares